BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26244650)

  • 1. Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Leal MC; Däbritz J
    Inflamm Bowel Dis; 2015 Dec; 21(12):2936-47. PubMed ID: 26244650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer.
    Li Y; de Haar C; Peppelenbosch MP; van der Woude CJ
    Cytokine Growth Factor Rev; 2012 Jun; 23(3):127-38. PubMed ID: 22591635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells in the inflammatory bowel diseases.
    Ostanin DV; Bhattacharya D
    Inflamm Bowel Dis; 2013 Oct; 19(11):2468-77. PubMed ID: 23811636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation.
    Amodio G; Cichy J; Conde P; Matteoli G; Moreau A; Ochando J; Oral BH; Pekarova M; Ryan EJ; Roth J; Sohrabi Y; Cuturi MC; Gregori S
    Cancer Immunol Immunother; 2019 Apr; 68(4):661-672. PubMed ID: 30357490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons have opposing effects during the emergence and recovery phases of colitis.
    Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T
    Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages in intestinal homeostasis and inflammation.
    Bain CC; Mowat AM
    Immunol Rev; 2014 Jul; 260(1):102-17. PubMed ID: 24942685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease.
    Patel AA; Ginhoux F; Yona S
    Immunology; 2021 Jul; 163(3):250-261. PubMed ID: 33555612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and Innate-Like Immune System in Hypertension and Vascular Injury.
    Higaki A; Caillon A; Paradis P; Schiffrin EL
    Curr Hypertens Rep; 2019 Jan; 21(1):4. PubMed ID: 30659373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the cellular immunology of the intestine in relation to the pathophysiology of inflammatory bowel diseases.
    Latinne D; Fiasse R
    Acta Gastroenterol Belg; 2006; 69(4):393-405. PubMed ID: 17343083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Features of Human Myeloid Cell Cytokine Response Profiles Identify Neutrophil Activation by Cytokines as a Prognostic Feature during Tuberculosis and Cancer.
    Devlin JC; Zwack EE; Tang MS; Li Z; Fenyo D; Torres VJ; Ruggles KV; Loke P
    J Immunol; 2020 Jun; 204(12):3389-3399. PubMed ID: 32350082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages?
    Bar-On L; Zigmond E; Jung S
    Semin Immunol; 2011 Feb; 23(1):58-64. PubMed ID: 21292502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
    Mao Y; Poschke I; Kiessling R
    J Intern Med; 2014 Aug; 276(2):154-70. PubMed ID: 24597954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease.
    Leon F; Smythies LE; Smith PD; Kelsall BL
    Adv Exp Med Biol; 2006; 579():117-32. PubMed ID: 16620015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
    Xu XM; Zhang HJ
    World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of inflammatory bowel disease and molecular targets for biologics.
    Dave M; Papadakis KA; Faubion WA
    Gastroenterol Clin North Am; 2014 Sep; 43(3):405-24. PubMed ID: 25110250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immune-related myeloid cells in angiogenesis.
    Chambers SE; O'Neill CL; O'Doherty TM; Medina RJ; Stitt AW
    Immunobiology; 2013 Nov; 218(11):1370-5. PubMed ID: 23932437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among myeloid regulatory cells in cancer.
    Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
    Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.